SCHEMBL31108248

SCHEMBL31108248

COC(=O)[C@@H]1CCCCN1Cc1ccc(C(=O)Nc2cccc(-c3cccc(NC(=O)c4ccc(CNCCNC(=O)CCCNC(=O)OC(C)(C)C)cn4)c3Cl)c2Cl)nc1

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CD274 Q9NZQ7 19/20 0.50
▸ PDCD1 Q15116 18/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31108223 0.98 PDCD1 (0.51) CD274PDCD1
SCHEMBL31108358 0.94 PDCD1 (0.54) CD274PDCD1
SCHEMBL31108334 0.91 PDCD1 (0.47) CD274PDCD1
SCHEMBL31108224 0.90 CD274 (0.53) CD274PDCD1
SCHEMBL31108333 0.88 PDCD1 (0.49) CD274PDCD1
SCHEMBL31108320 0.88 PDCD1 (0.55) CD274PDCD1
SCHEMBL31108351 0.86 PDCD1 (0.56) CD274PDCD1
SCHEMBL31108259 0.86 PDCD1 (0.56) CD274PDCD1
SCHEMBL31108235 0.85 PDCD1 (0.53) CD274PDCD1
SCHEMBL31108284 0.84 PDCD1 (0.58) CD274PDCD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4694981-A1 HETEROCYCLIC COMPOUNDS AS DUAL INHIBITORS OF PD-L1 AND ADENOSINE RECEPTORS Aurigene Oncology Limited (IN) 2026-02-18 — — EP disclosed
WO-2024214088-A1 HETEROCYCLIC COMPOUNDS AS DUAL INHIBITORS OF PD-L1 AND ADENOSINE RECEPTORS AURIGENE ONCOLOGY LIMITED (IN) 2024-10-17 — — WO disclosed
Send feedback